Vertex Pharmaceuticals Incorporated (VRTX) has 5,431,600 shares of shorts outstanding as on August 15, 2016, with 4 days left to cover or roll them over. On Jul 29, 2016, the open interest of short positions was 5,667,595 shares. The stock has a decent trading volume of 1,268,083 shares daily. The marginal decrease in the short positions is by -4.2%, which amounts to -235,995 shares. Short positions are 2.2% of the available float. The short interest information was released on Wednesday Aug 24th after the market close.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): The stock opened at $101.20 on Wednesday but the bulls could not build on the opening and the stock topped out at $102.49 for the day. The stock traded down to $96.27 during the day, due to lack of any buying support eventually closed down at $96.71 with a loss of -4.24% for the day. The stock had closed at $100.99 on the previous day. The total traded volume was 1,494,528 shares.
In a related news, The Securities and Exchange Commission has divulged that Boger Joshua S, director of Vertex Pharmaceuticals Inc / Ma, had unloaded 6,900 shares at an average price of $99.79 in a transaction dated on August 17, 2016. The total value of the transaction was worth $688,551.
Vertex Pharmaceuticals Incorporated (Vertex) is a global biotechnology company. The Company is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The Company uses precision medicine approaches to create transformative drugs for patients with serious diseases in specialty markets. Vertexs business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF). It is also engaged in other research and early-stage development programs, including programs in the areas of oncology and neurology. The Companys product candidates include KALYDECO (ivacaftor), Lumacaftor in combination with Ivacaftor, VX-661 in combination with Ivacaftor, VX-803, VX-970 and VX-222. The Companys product KALYDECO is available in the market.